Genetic Variants and Tumor Immune Microenvironment: Clues for Targeted Therapies in Inflammatory Breast Cancer (IBC).
To better understand the etiology of inflammatory breast cancer (IBC) and identify potential therapies, we studied genomic alterations in IBC patients. Targeted, next-generation sequencing (NGS) was performed on cell-free DNA (cfDNA) (
Published In/Presented At
Gong, Y., Nagarathinam, R., Arisi, M. F., Gerratana, L., Winn, J. S., Slifker, M., Pei, J., Cai, K. Q., Hasse, Z., Obeid, E., Noriega, J., Sebastiano, C., Ross, E., Alpaugh, K., Cristofanilli, M., & Fernandez, S. V. (2021). Genetic Variants and Tumor Immune Microenvironment: Clues for Targeted Therapies in Inflammatory Breast Cancer (IBC). International journal of molecular sciences, 22(16), 8924. https://doi.org/10.3390/ijms22168924
Medicine and Health Sciences
Department of Pathology and Laboratory Medicine